| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |